8-KCorporate ChangesExhibits & Filings

Cigna Group 8-K Report, Bylaw Amendment (Oct 28, 2022)

Filed October 28, 2022For Securities:CI

Summary

Cigna Group (CI) filed an 8-K on October 28, 2022, to report a procedural update to its corporate governance. The Board of Directors unanimously adopted Restated By-Laws, effective October 26, 2022. These changes are primarily driven by new SEC rules concerning universal proxy cards and recent amendments to Delaware General Corporation Law. The amendments focus on updating the mechanics for shareholder nominations of directors, modifying adjournment procedures, and enhancing the clarity around stockholder lists for voting at meetings. These are largely technical and conforming changes aimed at aligning Cigna's governance practices with current regulatory and legal requirements, rather than reflecting a change in strategic direction or financial performance.

Key Highlights

  • 1Cigna Group (CI) updated its corporate bylaws to comply with new SEC universal proxy card rules (Rule 14a-19).
  • 2The Restated By-Laws also incorporate recent amendments to Delaware General Corporation Law.
  • 3Key changes include updated procedural mechanics for shareholder director nominations.
  • 4Provisions related to meeting adjournment procedures have been modified.
  • 5The by-laws now reflect updated procedures for compiling stockholder lists eligible to vote.
  • 6These are primarily administrative and conforming changes to Cigna's governance documents.
  • 7The filing was made on October 28, 2022, with an effective date of October 26, 2022.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce the adoption of Restated By-Laws by Cigna Group's Board of Directors. These changes are intended to align the company's governance procedures with new Securities and Exchange Commission (SEC) rules regarding universal proxy cards and recent updates to Delaware General Corporation Law.

No, the changes detailed in this 8-K are primarily procedural and administrative. They update the mechanics of director nominations and shareholder meeting procedures to comply with regulatory and legal requirements. They do not indicate any shift in Cigna's business strategy, financial health, or operational performance.

The Restated By-Laws update procedural mechanics for shareholder director nominations to address SEC Rule 14a-19, modify provisions related to adjournment procedures at meetings, and update rules concerning lists of stockholders entitled to vote. They also include various other minor, conforming changes.

The full text of the Restated By-Laws, dated October 26, 2022, is filed as Exhibit 3.2 to this Current Report on Form 8-K and is incorporated by reference.